Hepagene Therapeutics Inc

Hepagene Therapeutics, Inc. develops biopharmaceutical products for liver diseases. The Company focuses on discovering, developing, and commercializing novel therapies for NASH, HBV, and other life-threatening conditions. Hepagene Therapeutics Inc serves patients in the United States and China.